Canton Strategic Holdings, Inc. (CNTN) Stock
Canton Strategic stock price chart
CNTN stock quote & key statistics
Canton Strategic annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0 | -$35.9M | -$2.76 |
| FY2024 | $0 | -$12.2M | -$9.68 |
| FY2023 | $0 | -$9.3M | -$188.80 |
| FY2022 | $0 | -$8.5M | -$284.10 |
| FY2021 | $0 | -$2.2M | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States. The company operates as a validator and super validator on the Canton Network, which provides validation and liveness services to the network. It also provides locking-as-a-service (LaaS) to Canton Network super validators and featured applications, which locks its own Canton Coin (CC) on a customer's behalf while retaining legal and beneficial ownership.
In addition, the company invests in the Canton ecosystem. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is based in New York, New York.
Canton Strategic stock FAQ
What is the Canton Strategic stock ticker symbol?
Canton Strategic Holdings, Inc. trades on the NASDAQ under the ticker symbol CNTN.
What sector and industry is Canton Strategic in?
Canton Strategic Holdings, Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does Canton Strategic have?
Canton Strategic Holdings, Inc. has about 12 full-time employees.
What were Canton Strategic's revenue and earnings last fiscal year?
Canton Strategic reported revenue of $0 and net income of -$35.9M in fiscal 2025, with earnings per share of -$2.76.
Is Canton Strategic in the Russell 2000?
Yes. Canton Strategic Holdings, Inc. (CNTN) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did Canton Strategic go public?
Canton Strategic stock began trading on January 12, 2022.
Russell 2000 Biotechnology stocks
All Russell 2000 →- CGONCG Oncology
- COGTCogent Biosciences
- CRSPCRISPR Therapeutics
- CYTKCytokinetics
- DFTXDefinium Therapeutics
- DNTHDianthus Therapeutics
- IBRXImmunityBio
- IOVAIovance Biotherapeutics
- KODKodiak Sciences
- KRYSKrystal Biotech
- KYMRKymera Therapeutics
- LGNDLigand Pharmaceuticals
- MIRMMirum Pharmaceuticals
- ORKAOruka Therapeutics
- PCVXVaxcyte
- PRAXPraxis Precision Medicines
- PTCTPTC Therapeutics
- PTGXProtagonist Therapeutics
- RYTMRhythm Pharmaceuticals
- SRRKScholar Rock
- SYRESpyre Therapeutics
- TGTXTG Therapeutics
- TVTXTravere Therapeutics
- TWSTTwist Bioscience